Explore the full directors' dealings record of 신라젠, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 신라젠 has logged 1 insider filings. Market capitalisation: €415.8bn. The latest transaction was disclosed on 5 March 2026 — Other. Among the most active insiders: 신라젠. Every trade is openly available.